Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: A community-based study

Digestive Diseases and Sciences

Volumn 57, Issue 5, 2012, Pages 1373-1383

  Zhang, Sue ^a,b   Garcia, Ruel T ^a,c   Ristau, Jessica T ^a   Nguyen, Huy A ^c   Trinh, Huy N ^a,c   Nguyen, Mindie H ^d  

^a Pacific Health Foundation   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c San Jose Gastroenterology   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asian American; Chronic hepatitis B; Hepatitis B treatment guidelines; Hepatitis B virus; Undertreatment

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA; ANTIVIRUS AGENT;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALGORITHM; ANTIVIRAL THERAPY; ARTICLE; CHRONIC HEPATITIS; FAMILY HISTORY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; THROMBOCYTE COUNT; TREATMENT REFUSAL; ASIAN AMERICAN; BLOOD; DRUG EFFECT; ETHNOLOGY; GENETICS; HEALTH CENTER; INFORMATION PROCESSING; METABOLISM; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT; PATIENT SELECTION; STATISTICS; UNITED STATES; VIROLOGY;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASIAN AMERICANS; COMMUNITY HEALTH CENTERS; DATA COLLECTION; DNA, VIRAL; ELIGIBILITY DETERMINATION; FEMALE; GUIDELINE ADHERENCE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PATIENT SELECTION; RETROSPECTIVE STUDIES; TREATMENT REFUSAL; UNITED STATES;

EID: 84863616619     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2137-0     Document Type: Article

References (39)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97-107.
2. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6: 1315-1341. quiz 1286.
3. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661-662.
4. Centers for Disease Control and Prevention (CDC). Screening for chronic hepatitis B among Asian/Pacific islander populations: New York City, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:1-24.
5. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25:3-8.
6. Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54:1-31.
7. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. MMWR Recomm Rep. 2006;55:1-33. quiz CE31-34.
8. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health. 1999;89:14-18.
9. Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202:192-201.
10. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000;118:554-559.
11. Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346: 1682-1683.
12. Choi MS, Yoo BC. Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelines. Gut Liver. 2010;4:15-24.
13. LiawYF,Hepatitis B. virus replication and liver disease progression: the impact of antiviral therapy. Antivir Ther. 2006;11:669-679.
14. Ayoub WS, Keeffe EB. Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther. 2008;28:167-177.
15. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol. 2004;2:87-106.
16. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2001; 34:1225-1241.
17. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007; 45:507-539.
18. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4:936-962.
19. Giannini EG, Torre F, Basso M, et al. A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: a region-wide survey in Italy. J Clin Gastroenterol. 2009;43:1001-1007.
20. Jung CW, Tan J, Tan N, et al. Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population. J Gastroenterol Hepatol. 2010;25:369-375.
21. Reau N. Practitioners advise therapy outside of HBV treatment guidelines more frequently in HBeAg positive patients and more often when using AASLD compared to EASL guidelines [abstract]. Gastroenterology. 2010;138:S-794.
22. Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008; 57:1-20.
23. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007;46:1034-1040.
24. Wu CA, Lin SY, So SK, Chang ET. Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev. 2007;8:127-134.
25. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19:1409-1417.
26. Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat. 2010; 18:377-383.
27. Keeffe EB, Zeuzem S, Koff RS, et al. Report of an international workshop: roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroenterol Hepatol. 2007; 5:890-897.
28. Dienstag JL. Benefits and risks of nucleoside analog therapy for hepatitis B. Hepatology. 2009;49:S112-S121.
29. Taylor BC, Yuan JM, Shamliyan TA, Shaukat A, Kane RL, Wilt TJ. Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: a systematic review of evidence. Hepatology. 2009;49:S85-S95.
30. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007;47:760-767.
31. Perrillo RP, Jacobson IM. Halting the natural history of hepatitis B viral infection: a paradigm shift. Semin Liver Dis. 2007;27:3-8.
32. Yuen MF, Yuan HJ, Wong DK, et al. Prognostic determinants for chronic hepatitis B in Asians: Therapeutic implications. Gut. 2005;54:1610-1614.
33. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328:983.
34. Tsang PS, Trinh H, Garcia RT, et al. Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. Clin Gastroenterol Hepatol. 2008;6:569-574.
35. Lim JK, Ayoub WS, Nguyen MH. Histological disease in patients with chronic hepatitis B, high HBV DNA, and normal alanine aminotransferase levels. Curr Hepat Rep. 2010;2:65-74.
36. Kumar M, Sarin SK, Hissar S, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology. 2008;134:1376-1384.
37. Tong MJ, Hsien C, Hsu L, Sun HE, Blatt LM. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States. Hepatology. 2008;48:1070-1078.
38. Hu KQ, Hepatitis B. virus (HBV) infection in Asian and Pacific Islander Americans (APIAs): how can we do better for this special population? Am J Gastroenterol. 2008;103:1824-1833.
39. Tong MJ, Pan CQ, Hann HW, et al. The management of chronic hepatitis B in Asian Americans. Dig Dis Sci. 2011;56:3143-3162.